The authors noticed that deletion mutation of Fgf14 may cause and/or accelerate tauopathy-like phenotypes in rTg4510 mice and cautioned against the use of rTg4510 mice for drug screening (Gamache et al., 2019). Here, FGF14 is linked to tauopathy.